BackLiminatus Pharma Class A Common Stock Overview

Liminatus Pharma Class A Common Stock Total Assets

Liminatus Pharma Class A Common Stock's total assets is $3.4M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$3.40M
↑ 78.32% YoYΔ $1.49M vs prior year quarter

Peer trimmed avg / median

Loading

Liminatus Pharma Class A Common Stock Total Assets History

Loading

Liminatus Pharma Class A Common Stock vs. peers: Total Assets Comparison

Loading

Liminatus Pharma Class A Common Stock Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Liminatus Pharma Class A Common Stock (LIMN) FAQ

As of the most recent data (June 2026), LIMN shows a total assets of $3.4M. That compares with $1.9M in the prior-year period — up 78.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIMN's total assets is now $3.4M (was $1.9M) — a 78.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Liminatus Pharma Class A Common Stock is outperforming or lagging.

Tracking LIMN's total assets over time shows whether Liminatus Pharma Class A Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $3.4M That compares with $1.9M in the prior-year period — up 78.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Liminatus Pharma Class A Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $3.4M) with ownership activity and broader fundamentals.